Millions of travelers suffer from jet lag every year. And now Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) said one of its drugs successfully addressed the problem with hundreds of volunteers in a late-stage clinical trial.
Symbiont Health, maker of innovative technology to detect falls for seniors and nursing home patients, took home the $15,000 grand prize at yesterday’s Pitch Dingman Competition, the University of Maryland’s business competition chaired by businessman and philanthropist Robert G. Hisaoka. The competition awarded nearly $30,000 in seed funding to top student entrepreneurs in a “Shark Tank”-style pitch session, hosted by the Dingman Center for Entrepreneurship at the Robert H. Smith School of Business.
Sonavex, Inc. announced today the final closure of its expanded $4.5M Series A and filing of a 510(k) submission to the U.S. Food and Drug Administration (FDA) for its EchoMark device. The proceeds will accelerate Sonavex’s commercial launch later this year and support further product development. Participants in the additional financing included Fusion Fund (aka NewGen Capital), FundRx, and existing investors.
Get answers from experienced entrepreneurs and legal/business professionals on how to build a successful startup company. Receive free and impartial advice, brainstorm business strategies, investigate funding opportunities and learn about the vast resources available to entrepreneurs.
Wednesday, March 14, 2018, 4-6 p.m.
TAP Building, 387 Technology Drive, Room 1105, UMD
Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced financial results for the year ended December 31, 2017.
The dispute is already underway. In August, the Trump administration initiated a sweeping investigation into Chinese trade practices, including whether Chinese firms are investing in U.S. companies to steal their technology and whether they are forcing joint ventures, pressuring American companies that invest in China to transfer technology to a Chinese partner, or hacking U.S. companies’ software.
The Centers for Medicare and Medicaid Services has announced a new initiative designed to provide patients access to their electronic health records and share their data with their preferred health care providers.
New compounds targeting epigenetics have shown remarkable early activity in patients with lymphoma, according to data presented at the TAT (Targeted Anticancer Therapies) International Congress 2018 in Paris, France. ESMO’s phase-I oncology meeting featured early clinical studies with BET inhibitors and EZH2 inhibitors.
Life science industry impacts N.J. economy in big way, C&W report says By Emily Bader New Jersey | Mar 7, 2018 at 11:44 am
The life science industry is fueling New Jersey’s economy through revenue and job growth, according to a report by Cushman & Wakefield.
Will Your Company be the Buzz of BIO?
Are you an innovative biotech company that is R&D-intensive and looking to develop strategic partnerships within the industry? Nominate your company to be the Buzz of BIO!
Winners receive complimentary registration that includes BIO One-on-One Partnering™, a Company Presentation slot in the BIO Business Forum, and marketing promotion to thousands of industry leaders.
Nominations End March 16